7 Apr 2017
Following the clearance from US Department of Justice on March 31st 2017 Smiths Group plc today confirms that it has completed the acquisition of Morpho Detection.
Consistent with the clearance from the European Commission, the DOJ approval is conditional on the post-completion divestment of Morpho Detection’s explosive trace detection business.
Contact details
Investor enquiries
Andrew Lappin, Smiths Group
+44 (0)20 7004 1657
+44 (0)78 0500 7035
andrew.lappin@smiths.com
Marion Le Bot, Smiths Group
+44 (0)20 7004 1672
+44 (0)75 8315 4386
marion.lebot@smiths.com
Media enquiries
Andrew Lorenz, FTI Consulting
+44 (0)203 727 1323
+44 (0)777 564 1807
smiths@fticonsulting.com
Deborah Scott, FTI Consulting
+44 (0)203 727 1459
+44 (0)797 953 7449
smiths@fticonsulting.com
Smiths Group is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Smiths Group employs more than 22,000 people in over 50 countries. For more information visit www.smiths.com
Smiths Detection is a leading global designer and manufacturer of sensors that detect and identify explosives, weapons, chemical agents, biohazards, nuclear and radioactive material, narcotics and contraband. Its range of detection technologies, including X-ray, trace detection and infra-red spectroscopy helps customers in the global transportation, ports and borders, critical infrastructure, military and emergency responder markets. Smiths Detection generated annual sales of £526 million for the year to 31 July 2016 and has over 2,000 employees worldwide. Smiths Detection’s manufacturing centres are located in Germany, France, Malaysia, USA and the UK, and its products are sold in over 200 countries.